Greylin Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,115
| Closed | -$223K | – | 83 |
|
|
2024
Q1 | $223K | Sell |
4,115
-750
| -15% | -$40.7K | 0.04% | 76 |
|
|
2023
Q4 | $250K | Buy |
+4,865
| New | +$250K | 0.04% | 68 |
|
|
2014
Q4 | – | Sell |
-3,950
| Closed | -$202K | – | 63 |
|
|
2014
Q3 | $202K | Buy |
+3,950
| New | +$202K | 0.05% | 64 |
|
|
2014
Q2 | – | Sell |
-5,150
| Closed | -$268K | – | 69 |
|
|
2014
Q1 | $268K | Sell |
5,150
-1,074
| -17% | -$55.9K | 0.07% | 61 |
|
|
2013
Q4 | $331K | Sell |
6,224
-276
| -4% | -$14.7K | 0.08% | 62 |
|
|
2013
Q3 | $301K | Hold |
6,500
| – | – | 0.15% | 32 |
|
|
2013
Q2 | $290K | Buy |
+6,500
| New | +$290K | 0.09% | 34 |
|